Editas Medicine Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Amyris and Caribou Biosciences.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | |
Founding Date | Founding Date 2013 | Founding Date 2003 | Founding Date 2012 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Emeryville, US HQ Sao Paulo, BR | Locations Berkeley, US HQ |
Employees | Employees 20816% increase | Employees 1,0031% decrease | Employees 1477% decrease |
Valuation ($) | Valuation ($) 256.5 m | Valuation ($) N/A | Valuation ($) 174.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income ($160.1m) (FY, 2025) | Net income ($543.4m) (FY, 2022) | Net income ($148.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 210m | Total funding raised $ 551.9m | Total funding raised $ 159.5m |
For sources of this data, please see the company profile
View Company Profiles
Amyris
HQ
Emeryville, US
Employees
1,003↓ 1% decrease
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company